Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study

Summary Background Newborn screening for cystic fibrosis might not be introduced if implementation and running costs are perceived as prohibitive. Compared with clinical diagnosis, newborn screening is associated with clinical benefit and reduced treatmen